Acute renal injury Sepsis
Conditions
Interventions
This is a prospective, randomized clinical trial that will evaluate the prevention of hypotension during hemodialysis sessions in patients with acute kidney injury associated with sepsis. An estimated
Sponsors
Departamento de Suporte às Unidades de Saúde
Faculdade de Medicina de Botucatu
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients admitted to the Intensive Care Units (ICU) of the Hospital das Clínicas of the Faculty of Medicine of Botucatu; over 18 years of age; with Acute Kidney Injury associated with sepsis; in acute renal support therapy undergoing Hemodialysis; using norepinephrine at a dose of 0.2 to 0.6 ucg/kg/min and being monitored by the Acute Kidney Injury group of the nephrology service
Exclusion criteria
Exclusion criteria: Patients undergoing chronic renal replacement therapy (Chronic Kidney Disease dialysis and kidney transplant) and treated with less than two prolonged hemodialysis sessions will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to reduce episodes of intradialytic hypotension through the solutions used at the beginning of the session in order to assess whether any of them has a better benefit for the participant to be able to complete the 6-hour therapy in full | — |
Secondary
| Measure | Time frame |
|---|---|
| Using the method we hope to carry out the therapy for the prescribed time, as this is sometimes not possible due to hypotension. In this way, the participant improves their clinical condition, managing to achieve metabolic and volume control through hemodialysis | — |
Countries
BR
Contacts
Public ContactMarci Maira Lunardi
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Outcome results
None listed